Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Limmat Capital to become investment manager of large balanced fund mandate

Monday, February 17, 2014
Opalesque Industry Update - With a focus on producing stable long-term returns by investing in bonds, equities, precious metals and alternative investments,LIMMAT CAPITAL Alternative Investments AG has been appointed to manage a large balanced fund mandate starting on February 1. Limmat Capital is an independent FINMA regulated investment management firm in Zurich, Switzerland, specializing in liquid long/short equity and balanced fund strategies.

Launched in 2009, the mandated strategy has assets under management of EUR 196 million, bringing Limmat Capital's total assets under management to CHF 360 million. The mandate's goal is the balancing of long-term returns across market cycles and the preservation of capital under difficult market circumstances. "Compounding matters. By 'compounding' we mean the positive, steady, eventless and therefore boring compounding of capital" said Frederick Barnard, head of research and portfolio manager of the mandate, who has been involved in managing this type of mandate since 1995. Liquidity is of paramount importance in the current financial markets. Therefore the vast majority of the strategy's investments are in liquid instruments.

Last year, Limmat Capital delivered profits to the investors for the ninth consecutive year in its equity flagship strategy, maintaining a strong risk-adjusted return of 13% p.a. with a maximum draw-down of 5.3%, no down year and a lifetime Sharpe Ratio of 2.0 since inception in 2005. Further, the company was approved by the Swiss Financial Market Supervisory Authority (FINMA) as asset manager of foreign collective investment schemes on January 3. The FINMA license marks another important step towards becoming an internationally recognized multi-disciplinary investment management firm and alternative investment platform.

Limmat Capital has evolved from a proprietary trading boutique into a multi-disciplinary investment management firm with a vision to inspire an inventive culture and achieve the full potential and prosperity for clients, employees and partners.

"The long-term interests of our investors are central to how we approach our business and the way we manage our growth. Including this new strategy, our growth revolves around building and expanding our platform in a controlled and intelligent fashion and gaining this new mandate reflects our approach to running business," added Limmat Capital CEO Raphael Rutz, who is also the company's co-founder. "We believe our focus on delivering consistent long-term positive risk-adjusted returns to our investors will also serve the best interests of our business partners and our firm."

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for